BSECompany Update26 Aug 2026 · 26 Aug 2026, 04:18 pm

Schedule of Analyst/Institutional Investor Meeting

IOL Chemicals & Pharmaceuticals Ltd · 524164

✦ AI Summary

IOL Chemicals & Pharmaceuticals Ltd has announced a schedule for an analyst/institutional investor meeting on 3rd September 2026, organized by Phillip Capital (India) Private Limited. The meeting will be held in person and will focus on past financial results and publicly available information. No unpublished price-sensitive information will be disclosed.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact8/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

IOL Chemicals & Pharmaceuticals Ltd - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Attachments (1)

📄

6870b63e-3efc-4f8b-a3cd-2044790a9297.pdf

pdf

Download →
View document text
26th August 2026 IOLCP/CGC/2026 National Stock Exchange of India Ltd. BSE Limited Exchange Plaza, Plot no. C/1, G Block, Phiroze Jeejeebhoy Towers, Bandra-Kurla Complex, Bandra (E), Mumbai – 400051 Dalal Street, Mumbai- 400 001 Security Symbol: IOLCP Security Code: 524164 Sub: Schedule of Analyst/Institutional Investor Meeting Dear Sirs, Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 (“SEBI LODR Regulations”), we would like to inform that the management of the Company will be interacting with Institutional Investors / analysts as per following schedule: Date Details pertaining to the meet Mode Nature of the meeting One-day corporate access event 3rd September “Market Marvel - Investing Beyond the 2026, In Person One-on-one Meeting Headlines” organised by Phillip Thursday Capital (India) Private Limited The discussion during the meeting will be limited to past financial results and information about the Company already available in the public domain. No unpublished price-sensitive information (UPSI) will be disclosed. Please note that the above schedule is subject to change due to unforeseen circumstances, such as last-minute changes in investor/broker participation or cancellations. This information will also be accessible on the Company’s website: www.iolcp.com. Thanking you. Yours faithfully, for IOL Chemicals and Pharmaceuticals Limited Abhay Raj Singh Sr. Vice President & Company Secretary